Seattle company’s cannabis candies could fuel boom in stock shares

From All Marijuana Stocks | Ad

A popular Seattle cannabis manufacturer recently announced the roll-out of an all-new line of premium infused edibles, marketed under the brand name “Goodies.” Hand-crafted, gluten-free, and using all-natural ingredients, the candies and caramels contain micro-dose servings of just 5-mg THC for a controlled, measured experience.

Get a FREE report on new pot stock blockbuster

MRTX Insider Trading (Mirati Therapeutics)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.12%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $244,654,297.90

Mirati Therapeutics Insider Trading History Chart

Mirati Therapeutics Share Price & Price History

^$159.86

▲ +1.66 (1.05%)

As of 07/29/2021 01:00 AM ET

Days: 30 | 90 | 365

The Only Futures Trading Guide You’ll Ever Need

From RJO Futures | Ad

Regardless of your level of futures trading prowess, our Technical Analysis Guide has something to help you succeed in today’s futures markets.

Download your FREE Technical Analysis Trading Guide Today!

Mirati Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/18/2021	Charles M Baum	CEO	Sell	40,000	$165.46	$6,618,400.00	152,714
5/24/2021	Jamie Christensen	EVP	Sell	435	$154.34	$67,137.90	53,850
4/5/2021	Bruce L A Carter	Director	Sell	2,250	$177.11	$398,497.50	5,725
3/19/2021	Benjamin Hickey	EVP	Sell	2,369	$176.44	$417,986.36	29,181
3/9/2021	Ltd. Braslyn	Major Shareholder	Sell	11,971	$197.67	$2,366,307.57
3/5/2021	Boxer Capital, Llc	Major Shareholder	Sell	400,005	$181.15	$72,460,905.75
2/2/2021	Bruce L A Carter	Director	Sell	2,250	$191.12	$430,020.00
2/2/2021	Daniel Faga	COO	Sell	1,340	$194.38	$260,469.20
1/29/2021	Maria E Martinez	Director	Sell	7,500	$203.54	$1,526,550.00	10,975
1/21/2021	Craig A Johnson	Director	Sell	15,000	$211.55	$3,173,250.00	18,475
1/7/2021	Benjamin Hickey	EVP	Sell	2,078	$216.33	$449,533.74	21,858
1/7/2021	Daniel Faga	COO	Sell	2,625	$216.33	$567,866.25	26,228
1/6/2021	Charles M Baum	CEO	Sell	4,511	$210.39	$949,069.29	91,933
1/6/2021	Vickie S Reed	CAO	Sell	538	$210.39	$113,189.82	8,239
12/18/2020	Charles M Baum	CEO	Sell	40,000	$234.48	$9,379,200.00	142,023
12/15/2020	Henry J Fuchs	Director	Sell	10,000	$233.39	$2,333,900.00
10/30/2020	Boxer Capital, Llc	Major Shareholder	Sell	400,000	$202.00	$80,800,000.00
10/28/2020	Ltd. Braslyn	Major Shareholder	Sell	295,436	$206.57	$61,028,214.52
8/10/2020	Henry J Fuchs	Director	Sell	10,000	$131.38	$1,313,800.00	12,000
6/12/2020	Ltd. Braslyn	Major Shareholder	Sell	600,000	$69.00	$41,400,000.00	2,535,966
5/11/2020	Isan Chen	EVP	Sell	33,334	$105.00	$3,500,070.00	72,735
4/20/2020	Craig A Johnson	Director	Sell	15,000	$93.00	$1,395,000.00	17,000
4/17/2020	Charles M Baum	CEO	Sell	40,000	$90.33	$3,613,200.00	146,466
1/10/2020	Boxer Capital, Llc	Major Shareholder	Buy	50,000	$97.50	$4,875,000.00
11/20/2019	Bruce L A Carter	Director	Sell	3,000	$94.74	$284,220.00	3,000
11/12/2019	Michael G Grey	Director	Sell	3,042	$102.44	$311,622.48	5,298
8/22/2019	Charles M Baum	CEO	Sell	51,810	$86.22	$4,467,058.20	117,851
8/21/2019	Bruce L A Carter	Director	Sell	3,000	$89.24	$267,720.00	3,000
8/12/2019	Michael G Grey	Director	Sell	3,042	$92.27	$280,685.34	4,840
7/23/2019	Avoro Capital Advisors Llc	Major Shareholder	Sell	62,500	$101.88	$6,367,500.00
7/17/2019	Boxer Capital, Llc	Major Shareholder	Sell	725,008	$98.30	$71,268,286.40
5/22/2019	Bruce L A Carter	Director	Sell	3,000	$75.20	$225,600.00	3,000
5/16/2019	Jamie A Donadio	CFO	Sell	7,500	$75.00	$562,500.00	7,721
5/13/2019	Michael G Grey	Director	Sell	5,760	$65.30	$376,128.00	7,100
3/20/2019	Venbio Select Advisor Llc	Major Shareholder	Sell	23,781	$72.80	$1,731,256.80
3/18/2019	Venbio Select Advisor Llc	Major Shareholder	Sell	125,000	$76.55	$9,568,750.00
3/1/2019	Boxer Capital, Llc	Major Shareholder	Sell	425,000	$69.00	$29,325,000.00
2/25/2019	Charles M Baum	CEO	Sell	51,810	$75.67	$3,920,462.70	117,851
2/20/2019	Bruce L A Carter	Director	Sell	3,000	$73.64	$220,920.00	3,000
2/20/2019	Venbio Select Advisor Llc	Major Shareholder	Sell	686,820	$73.00	$50,137,860.00
2/15/2019	Jamie A Donadio	CFO	Sell	7,500	$75.00	$562,500.00	7,721
2/14/2019	Christopher C Lemasters	EVP	Sell	60,000	$71.77	$4,306,200.00	60,000
1/29/2019	Craig A Johnson	Director	Sell	17,000	$61.46	$1,044,820.00	7,000
1/17/2019	Boxer Capital, Llc	Major Shareholder	Buy	150,000	$62.00	$9,300,000.00
1/8/2019	Aaron I Davis	Director	Sell	50,000	$47.68	$2,384,000.00	70,409
1/8/2019	Boxer Capital, Llc	Major Shareholder	Sell	550,000	$52.10	$28,655,000.00
8/23/2018	Charles M Baum	CEO	Sell	51,810	$57.55	$2,981,665.50	102,742

Insider Trading at Mirati Therapeutics?

Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Mirati Therapeutics and related companies.

SEC Filings (Institutional Ownership Changes) for Mirati Therapeutics (NASDAQ:MRTX)

Institutional Buying and Selling by Quarter

Mirati Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
7/29/2021	Emerald Advisers LLC	300	$48K	0.0%	-98.9%	0.001%
7/28/2021	Altfest L J & Co. Inc.	1,288	$0.21M	0.0%	N/A	0.003%
5/24/2021	Principal Financial Group Inc.	56,743	$9.72M	0.0%	+136.7%	0.110%
5/22/2021	Teachers Retirement System of The State of Kentucky	34,759	$5.95M	0.1%	-6.8%	0.068%
5/18/2021	Canada Pension Plan Investment Board	2,183	$0.37M	0.0%	+679.6%	0.004%
5/18/2021	PFM Health Sciences LP	309,780	$53.07M	1.6%	+22.3%	0.602%
5/18/2021	Utah Retirement Systems	5,900	$1.01M	0.0%	N/A	0.011%
5/18/2021	Voloridge Investment Management LLC	24,118	$4.13M	0.0%	+70.2%	0.047%
5/18/2021	Point72 Asset Management L.P.	267,400	$45.81M	0.2%	+24.1%	0.520%
5/18/2021	Eaton Vance Management	10,452	$1.79M	0.0%	+4.5%	0.020%
5/18/2021	Amundi Asset Management US Inc.	109,345	$18.73M	0.0%	-13.1%	0.213%
5/18/2021	State of Wisconsin Investment Board	71,218	$12.20M	0.0%	-21.8%	0.138%
5/18/2021	Morgan Stanley	53,618	$9.19M	0.0%	-75.6%	0.104%
5/18/2021	Orbimed Advisors LLC	1,221,200	$209.19M	2.0%	+6.6%	2.374%
5/18/2021	Great Point Partners LLC	135,000	$23.13M	4.8%	N/A	0.262%
5/18/2021	Boxer Capital LLC	2,000,000	$342.60M	11.6%	+13.3%	3.888%
5/18/2021	Cormorant Asset Management LP	275,000	$47.11M	1.0%	-15.4%	0.535%
5/18/2021	Cubist Systematic Strategies LLC	13,171	$2.26M	0.0%	+31.4%	0.026%
5/18/2021	Twinbeech Capital LP	1,780	$0.31M	0.0%	-77.1%	0.003%
5/18/2021	Old Well Partners LLC	1,229	$0.21M	0.1%	N/A	0.002%
5/18/2021	California State Teachers Retirement System	68,815	$11.79M	0.0%	-0.3%	0.134%
5/18/2021	Silverarc Capital Management LLC	5,000	$0.86M	0.5%	-75.0%	0.010%
5/17/2021	JS Capital Management LLC	3,500	$0.60M	0.0%	N/A	0.007%
5/17/2021	Perceptive Advisors LLC	3,474,505	$595.18M	7.5%	-5.9%	6.754%
5/17/2021	Fred Alger Management LLC	7,667	$1.31M	0.0%	-52.9%	0.015%
5/17/2021	Great West Life Assurance Co. Can	2,222	$0.38M	0.0%	+5.0%	0.004%
5/17/2021	Point72 Hong Kong Ltd	242	$41K	0.0%	-21.7%	0.000%
5/17/2021	AQR Capital Management LLC	17,225	$2.95M	0.0%	-16.0%	0.033%
5/17/2021	Royal Bank of Canada	46,059	$7.89M	0.0%	+35.7%	0.090%
5/17/2021	Armistice Capital LLC	536,000	$91.82M	2.1%	+97.1%	1.042%
5/17/2021	Edmond DE Rothschild Holding S.A.	48,360	$8.28M	0.2%	+17.4%	0.094%
5/17/2021	Rock Springs Capital Management LP	323,647	$55.44M	1.2%	-13.3%	0.629%
5/17/2021	Polar Capital Holdings Plc	40,000	$6.85M	0.0%	-20.0%	0.078%
5/17/2021	Putnam Investments LLC	33,856	$5.80M	0.0%	-3.1%	0.066%
5/17/2021	Price T Rowe Associates Inc. MD	1,532,500	$262.52M	0.0%	-1.7%	2.979%
5/17/2021	Davide Leone & Partners Investment Co Ltd.	11,117	$1.90M	0.2%	+60.7%	0.022%
5/17/2021	Woodline Partners LP	31,103	$5.33M	0.1%	N/A	0.060%
5/17/2021	Caas Capital Management LP	115,829	$19.84M	0.2%	N/A	0.225%
5/17/2021	Janus Henderson Group PLC	1,156,163	$198.05M	0.1%	+0.3%	2.248%
5/17/2021	Ameriprise Financial Inc.	302,642	$51.84M	0.0%	-0.9%	0.588%
5/17/2021	Hennion & Walsh Asset Management Inc.	25,394	$4.35M	0.3%	N/A	0.049%
5/17/2021	Nomura Holdings Inc.	4,500	$0.77M	0.0%	+273.1%	0.009%
5/17/2021	Acuta Capital Partners LLC	9,000	$1.54M	0.6%	N/A	0.017%
5/17/2021	Nuveen Asset Management LLC	214,841	$36.80M	0.0%	+2.5%	0.418%
5/17/2021	Senator Investment Group LP	115,000	$19.70M	0.4%	N/A	0.224%
5/17/2021	Thrivent Financial for Lutherans	4,495	$0.77M	0.0%	-13.3%	0.009%
5/17/2021	Atom Investors LP	7,896	$1.35M	0.2%	-30.6%	0.015%
5/17/2021	Camber Capital Management LP	125,000	$21.41M	0.7%	N/A	0.243%
5/17/2021	Centiva Capital LP	5,357	$0.92M	0.0%	+24.4%	0.010%
5/17/2021	Goldman Sachs Group Inc.	413,439	$70.82M	0.0%	-17.1%	0.804%
5/14/2021	Profund Advisors LLC	1,308	$0.22M	0.0%	+43.4%	0.003%
5/14/2021	Ghost Tree Capital LLC	50,000	$8.57M	2.0%	-50.0%	0.097%
5/14/2021	RTW Investments LP	1,333,232	$228.38M	3.6%	+26.4%	2.592%
5/14/2021	Arrowstreet Capital Limited Partnership	52,900	$9.06M	0.0%	-57.2%	0.103%
5/14/2021	Dimensional Fund Advisors LP	55,058	$9.43M	0.0%	+27.9%	0.107%
5/14/2021	Skye Global Management LP	4,400	$0.75M	0.0%	N/A	0.009%
5/14/2021	XTX Topco Ltd	3,150	$0.54M	0.3%	N/A	0.006%
5/14/2021	First Mercantile Trust Co.	711	$0.12M	0.0%	-30.8%	0.001%
5/14/2021	Algert Global LLC	2,373	$0.41M	0.1%	N/A	0.005%
5/14/2021	TD Asset Management Inc.	37,054	$6.35M	0.0%	+4.8%	0.072%
5/14/2021	UBS Asset Management Americas Inc.	464,090	$79.50M	0.0%	-5.7%	0.902%
5/14/2021	Dynamic Technology Lab Private Ltd	4,108	$0.70M	0.1%	+201.2%	0.008%
5/14/2021	Sectoral Asset Management Inc	79,081	$13.55M	1.0%	+7.4%	0.154%
5/14/2021	Credit Suisse AG	342,246	$58.63M	0.0%	+125.5%	0.665%
5/14/2021	O Shaughnessy Asset Management LLC	2,111	$0.36M	0.0%	-22.6%	0.004%
5/14/2021	Quantbot Technologies LP	955	$0.16M	0.0%	-36.3%	0.002%
5/13/2021	Guggenheim Capital LLC	21,036	$3.60M	0.0%	+15.3%	0.041%
5/13/2021	Franklin Resources Inc.	992,143	$169.95M	0.1%	+241.7%	1.929%
5/13/2021	QS Investors LLC	2,048	$0.35M	0.0%	-36.5%	0.004%
5/13/2021	SG Americas Securities LLC	14,079	$2.41M	0.0%	+691.4%	0.027%
5/13/2021	AlphaCrest Capital Management LLC	5,084	$0.87M	0.0%	+182.4%	0.010%
5/13/2021	ClariVest Asset Management LLC	2,315	$0.40M	0.0%	-4.1%	0.005%
5/13/2021	Barclays PLC	39,265	$6.73M	0.0%	+1.9%	0.076%
5/13/2021	Renaissance Technologies LLC	89,900	$15.40M	0.0%	-51.2%	0.175%
5/13/2021	Pier Capital LLC	44,218	$7.58M	0.7%	+63.2%	0.086%
5/13/2021	Mutual of America Capital Management LLC	29,547	$5.06M	0.1%	-0.7%	0.057%
5/13/2021	Amalgamated Bank	6,091	$1.04M	0.0%	-8.8%	0.012%
5/13/2021	Neuberger Berman Group LLC	17,673	$3.03M	0.0%	+2.5%	0.034%
5/13/2021	Alpine Global Management LLC	2,675	$0.46M	0.0%	N/A	0.005%
5/13/2021	Bank of New York Mellon Corp	159,494	$27.32M	0.0%	-17.6%	0.310%
5/13/2021	Citigroup Inc.	29,455	$5.05M	0.0%	-48.8%	0.057%
5/13/2021	Federated Hermes Inc.	156,839	$26.87M	0.1%	-35.2%	0.305%
5/13/2021	Mirae Asset Global Investments Co. Ltd.	6,310	$1.08M	0.0%	+7.8%	0.012%
5/13/2021	Bank of Montreal Can	2,325	$0.39M	0.0%	-67.0%	0.005%
5/13/2021	Aviva PLC	7,047	$1.21M	0.0%	-8.4%	0.014%
5/13/2021	Allianz Asset Management GmbH	23,531	$4.03M	0.0%	-6.8%	0.046%
5/12/2021	Northern Trust Corp	474,970	$81.36M	0.0%	-4.1%	0.923%
5/12/2021	Ergoteles LLC	12,200	$2.09M	0.1%	N/A	0.024%
5/12/2021	Geode Capital Management LLC	754,636	$129.27M	0.0%	+8.0%	1.467%
5/12/2021	Pura Vida Investments LLC	30,242	$5.18M	0.1%	+202.4%	0.059%
5/12/2021	Prudential Financial Inc.	10,806	$1.85M	0.0%	+231.1%	0.021%
5/12/2021	Ensign Peak Advisors Inc	26,737	$4.58M	0.0%	+33.2%	0.052%
5/12/2021	JPMorgan Chase & Co.	331,074	$56.71M	0.0%	-7.9%	0.644%
5/12/2021	E Fund Management Co. Ltd.	729	$0.13M	0.0%	N/A	0.001%
5/12/2021	Sei Investments Co.	11,906	$2.28M	0.0%	+27.9%	0.023%
5/12/2021	Sivik Global Healthcare LLC	10,000	$1.71M	0.6%	N/A	0.019%
5/12/2021	UBS Group AG	10,032	$1.72M	0.0%	-29.8%	0.020%
5/12/2021	Bellevue Group AG	9,800	$1.68M	0.0%	-20.3%	0.019%
5/11/2021	Aigen Investment Management LP	6,353	$1.09M	0.1%	+41.5%	0.012%
5/11/2021	Teacher Retirement System of Texas	3,862	$0.66M	0.0%	+48.8%	0.008%

Data available starting January 2016

Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase I/II clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; and Sitravatinib, an investigational spectrum-selective kinase inhibitor that is in Phase II clinical trial for the treatment of NSCL cancer, as well as a KRAS G12D inhibitor program, which is in preclinical development. It has a collaboration and license agreement with BeiGene, Ltd. to develop, manufacture, and commercialize sitravatinib; and a clinical collaboration agreement with Novartis Pharmaceuticals Corporation. Mirati Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California.

Today's Range

Now: $159.86

$158.34

$160.97

50 Day Range

MA: $162.23

$149.50

$172.25

52 Week Range

Now: $159.86

$116.08

$249.42

Volume

272,715 shs

Average Volume

494,601 shs

Market Capitalization

$8.22 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.33

Who are the company insiders with the largest holdings of Mirati Therapeutics?

Mirati Therapeutics' top insider shareholders include:

Ltd Braslyn (Major Shareholder)
Charles M Baum (CEO)
Isan Chen (EVP)
Jamie Christensen (EVP)
Benjamin Hickey (EVP)
Daniel Faga (COO)
Craig A Johnson (Director)
Henry J Fuchs (Director)
Maria E Martinez (Director)
Vickie S Reed (CAO)
Bruce L A Carter (Director)
Michael G Grey (Director)
Boxer Capital, Llc (Major Shareholder)

Who are the major institutional investors of Mirati Therapeutics?

Mirati Therapeutics' top institutional investors include:

Altfest L J & Co. Inc. — 0.00%
Emerald Advisers LLC — 0.00%

Which institutional investors are selling Mirati Therapeutics stock?

In the last quarter, MRTX stock was sold by these institutional investors:

Emerald Advisers LLC

During the last year, company insiders that have sold Mirati Therapeutics company stock include:

Ltd Braslyn (Major Shareholder)
Charles M Baum (CEO)
Isan Chen (EVP)
Jamie Christensen (EVP)
Benjamin Hickey (EVP)
Daniel Faga (COO)
Craig A Johnson (Director)
Henry J Fuchs (Director)
Maria E Martinez (Director)
Vickie S Reed (CAO)
Bruce L A Carter (Director)

Which institutional investors are buying Mirati Therapeutics stock?

Within the previous quarter, MRTX stock was acquired by institutional investors including:

Altfest L J & Co. Inc.

Invest In Psychedelic Therapy?

From Investing Trends | Ad

Psychedelic Therapy Clinics are popping up all over LA and Arizona. Some of them charge up to $2,000 for a full treatment... this is an emerging trend every investor should consider.

Tell Me More About Psychedelic Therapy